Neuromodulation in Speech Therapy Course

Lesson 1 • Neural Plasticity and Communication

Covers synaptic plasticity, Hebbian learning, and cortical reorganization as they apply to speech. Establishes the biological rationale for neuromodulation interventions.

Lesson 2 • Neurotransmitter Systems Overview

Examines dopamine, serotonin, acetylcholine, and GABA roles in motor speech and language. Links neurotransmitter function to observable communication behaviors.

Lesson 3 • Brain Regions Governing Speech

Maps Broca's area, Wernicke's area, basal ganglia, cerebellum, and motor cortex to specific speech functions. Provides anatomical grounding for targeted neuromodulation.

Lesson 1 • Contraindications and Risk Stratification

Identifies absolute and relative contraindications for each neuromodulation modality. Equips clinicians to stratify patient risk before recommending intervention.

Lesson 2 • Standardized Speech and Language Measures

Introduces validated tools for assessing articulation, fluency, voice, and language. Establishes baseline measurement practices essential for tracking neuromodulation outcomes.

Lesson 3 • Interdisciplinary Team Collaboration

Defines the speech-language pathologist's role within neurology, physiatry, and neuropsychology teams. Prepares clinicians to communicate assessment findings across disciplines.

Lesson 4 • Neuroimaging Interpretation Basics

Teaches clinicians to read MRI, fMRI, and CT reports relevant to speech pathology. Bridges radiology findings to neuromodulation target identification.

Lesson 1 • TMS Protocols for Aphasia

Reviews inhibitory rTMS over right-hemisphere homologs and excitatory protocols for perilesional cortex. Connects protocol selection to aphasia type and lesion location.

Lesson 2 • TMS Physics and Equipment

Explains electromagnetic induction, coil types, and stimulator parameters underlying TMS. Provides the technical literacy needed to operate and troubleshoot equipment.

Lesson 3 • Motor Threshold Determination

Teaches resting and active motor threshold measurement as the basis for individualized dosing. Accurate thresholds ensure safe and effective stimulation intensity.

Lesson 4 • TMS for Motor Speech Disorders

Applies TMS to dysarthria and apraxia of speech by targeting motor cortex and supplementary motor area. Differentiates protocol needs across motor speech subtypes.

Lesson 1 • tDCS Evidence for Specific Disorders

Critically reviews clinical trial evidence for tDCS in aphasia, dysarthria, stuttering, and voice disorders. Enables evidence-based protocol selection for each disorder type.

Lesson 2 • tDCS Mechanisms and Parameters

Explains anodal excitation and cathodal inhibition, current density, and charge calculations. Grounds parameter selection in neurophysiological evidence.

Lesson 3 • Electrode Montages for Speech Targets

Details montages targeting Broca's area, Wernicke's area, and motor cortex for specific speech goals. Accurate montage selection maximizes focality and therapeutic effect.

Lesson 1 • Dopaminergic Agents and Communication

Examines levodopa, bromocriptine, and dopamine agonists and their effects on motor speech and word retrieval. Provides the basis for timing therapy sessions around medication cycles.

Lesson 2 • Collaborative Prescriber Communication

Develops skills for communicating speech-relevant medication observations to physicians and pharmacists. Effective collaboration optimizes pharmacological and behavioral treatment synergy.

Lesson 3 • Medications That Impair Speech

Identifies antiepileptics, benzodiazepines, antipsychotics, and other agents that negatively affect speech fluency and voice. Prepares clinicians to flag medication-related communication changes.

Lesson 1 • Real-Time Acoustic Biofeedback

Uses spectrographic and pitch displays to provide real-time acoustic feedback during speech production. Enhances motor learning through augmented sensory information.

Lesson 2 • Respiratory and Laryngeal Biofeedback

Applies respiratory inductance plethysmography and laryngeal EMG to voice and fluency treatment. Targets physiological substrates of breath support and phonation control.

Lesson 3 • Surface EMG Biofeedback for Articulation

Teaches surface EMG placement, signal interpretation, and feedback delivery for articulatory muscle training. Provides a non-invasive tool for improving precision in motor speech disorders.

Lesson 4 • Neurofeedback Protocols for Stuttering

Reviews alpha and theta neurofeedback protocols targeting cortical overactivation associated with stuttering. Connects neural regulation to fluency improvement outcomes.

Lesson 1 • Discharge Planning and Maintenance

Establishes criteria for transitioning patients from active neuromodulation to maintenance and self-directed practice. Ensures durable gains through structured follow-up protocols.

Lesson 2 • Dosage and Intensity Progression

Applies principles of treatment intensity, massed vs. distributed practice, and stimulation dose escalation. Balances therapeutic gain against fatigue and adverse event risk.

Lesson 3 • Sequencing Modalities Within Sessions

Determines optimal ordering of neuromodulation and behavioral therapy within a single session. Proper sequencing exploits priming and state-dependent plasticity windows.

Lesson 4 • Multimodal Combination Strategies

Explores combining TMS, tDCS, pharmacology, and biofeedback within a single treatment plan. Evidence-based combinations are selected to maximize synergistic neuroplastic effects.

Lesson 1 • Pediatric Neuromodulation Considerations

Addresses developmental neuroplasticity, safety evidence, and ethical considerations for neuromodulation in children. Adapts adult protocols to pediatric populations with appropriate modifications.

Lesson 2 • Non-Responders and Treatment Resistance

Analyzes reasons for non-response including lesion characteristics, comorbidities, and protocol mismatch. Equips clinicians to systematically troubleshoot and pivot treatment strategies.

Lesson 3 • Ethical Decision-Making in Practice

Examines autonomy, beneficence, non-maleficence, and justice as applied to neuromodulation decisions. Prepares clinicians to navigate ethical dilemmas with structured frameworks.

Lesson 4 • Degenerative Disease Management

Applies neuromodulation to progressive conditions such as Parkinson's disease, ALS, and primary progressive aphasia. Focuses on slowing decline and maximizing functional communication.